1
|
Chopra S, Singh B, Koul A, Mishra AK, Robu S, Kaur A, Ghai A, Caplash N, Wester HJ. Radiosynthesis and pre-clinical evaluation of [ 68Ga] labeled antimicrobial peptide fragment GF-17 as a potential infection imaging PET radiotracer. Appl Radiat Isot 2019; 149:9-21. [PMID: 31003040 DOI: 10.1016/j.apradiso.2019.04.008] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2018] [Revised: 04/04/2019] [Accepted: 04/05/2019] [Indexed: 12/18/2022]
Abstract
The antimicrobial peptide fragment GF-17 was synthesized in-house and conjugated with DOTA and measured molecular mass of DOTA-GF-17 conjugate was 2489 Da. The peptide conjugate was purified and labeled with [68Ga]. The best radiolabeling efficiency (95.0%) of [68Ga]DOTA-GF-17 was achieved at pH 4 with peptide conjugate amount of 20.0 nmol with 30 min of heating at 95 °C. The product remained stable for up to 3 h. The plasma protein binding and lipophilicity for [68Ga]DOTA-GF-17 were 80.98% and -3.12 respectively. The uptake studies with [68Ga]DOTA- GF-17 in S.aureus and P.aeruginosa bacterial strains demonstrated binding of 69.08% and 43.69% respectively. The animal bio-distribution and PET imaging studies were in agreement showing similar pattern for organs' tracer distribution and renal excretion. The tracer had rapid blood clearance and uptake in bone marrow and muscles was very low. The highest uptake of [68Ga]DOTA-GF-17 was observed at 45 min and 120 min in S.aureus and P.aeruginosa infections respectively. [68Ga]DOTA-GF-17 could be a promising PET tracer and holds a great scope for taking the product further to perform extensive PET studies in animal infection (using gram negative/positive strains) models to prove the diagnostic utility of this novel PET tracer for futuristic clinical applications.
Collapse
Affiliation(s)
- Shalini Chopra
- Department of Nuclear Medicine & PET, Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh, 160012, India
| | - Baljinder Singh
- Department of Nuclear Medicine & PET, Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh, 160012, India.
| | - Ashwani Koul
- Department of Biophysics, Panjab University, Sector 25, Chandigarh, 160014, India
| | - Anil K Mishra
- Division of Cyclotron and Radiopharmaceutical Sciences, Institute of Nuclear Medicine and Allied Sciences, DRDO, Brig. S.K. Mazumdar Road, Timarpur, Delhi, 110054, India
| | - Stephanie Robu
- Department of Nuclear Medicine, Klinikum Rechts Der Isar, Technical University of Munich, Ismaninger Str. 22, 81675, Munich, Germany
| | - Amritjyot Kaur
- Department of Nuclear Medicine & PET, Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh, 160012, India
| | - Anchal Ghai
- Department of Radiology, School of Medicine, Washington University, 510 South Kingshighway Boulevard, St. Louis, Missouri, 63110-107, USA
| | - Neena Caplash
- Department of Biotechnology, Panjab University, Sector 25, Chandigarh, 160014, India
| | - Hans-Jürgen Wester
- Department of Nuclear Medicine, Klinikum Rechts Der Isar, Technical University of Munich, Ismaninger Str. 22, 81675, Munich, Germany
| |
Collapse
|